Jouvenceau A et al. |
Different phosphatase-dependent mechanisms mediate long-term depression and depotentiation of long-term potentiation in mouse hippocampal CA1 area. |
2003 |
Eur. J. Neurosci. |
pmid:12956726
|
Singh A et al. |
Protective effect of FK506 (tacrolimus) in pentylenetetrazol-induced kindling in mice. |
2003 |
Pharmacol. Biochem. Behav. |
pmid:12957228
|
Udina E et al. |
FK506 enhances reinnervation by regeneration and by collateral sprouting of peripheral nerve fibers. |
2003 |
Exp. Neurol. |
pmid:12957505
|
Murakami R et al. |
Cyclosporin A enhances interleukin-8 expression by inducing activator protein-1 in human aortic smooth muscle cells. |
2003 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:12958044
|
|
[Calcineurin inhibitors in treatment of atopic dermatitis. Topical corticoids now only in severe outbreaks? ]. |
2003 |
MMW Fortschr Med |
pmid:12958787
|
Jiménez O et al. |
Defining the initial doses of sirolimus and tacrolimus in the period immediately after renal transplantation. |
2003 |
Transplant. Proc. |
pmid:12962758
|
Sánchez-Fructuoso AI et al. |
Daclizumab induction as an immunosuppressive regimen for renal transplant recipients from non-heart-beating donors. |
2003 |
Transplant. Proc. |
pmid:12962759
|
Martin Garcia D et al. |
Tacrolimus-Basiliximab versus Cyclosporine-Basiliximab in renal transplantation "de novo": acute rejection and complications. |
2003 |
Transplant. Proc. |
pmid:12962761
|
Solà R et al. |
Tacrolimus in induction immunosuppressive treatment in renal transplantation: comparison with cyclosporine. |
2003 |
Transplant. Proc. |
pmid:12962763
|
Pascual J et al. |
Comparison between a two-drug regimen with tacrolimus and steroids and a triple one with azathioprine in kidney transplantation: results of a European trial with 3-year follow up. |
2003 |
Transplant. Proc. |
pmid:12962764
|
Urbizu JM et al. |
Safety and efficacy of tacrolimus rescue therapy in 55 kidney transplant patients treated with cyclosporine. |
2003 |
Transplant. Proc. |
pmid:12962765
|
Gentil MA et al. |
Safety and efficacy of delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors over 55 years of age. |
2003 |
Transplant. Proc. |
pmid:12962766
|
Hernández D et al. |
Cardiovascular risk profile in nondiabetic renal transplant patients: cyclosporine versus tacrolimus. |
2003 |
Transplant. Proc. |
pmid:12962773
|
Pascual J et al. |
A low incidence of new-onset insulin-dependent diabetes mellitus using tacrolimus in kidney recipients in Europe. |
2003 |
Transplant. Proc. |
pmid:12962785
|
Moreno JM et al. |
Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation. |
2003 |
Transplant. Proc. |
pmid:12962831
|
Herrero JI et al. |
Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus. |
2003 |
Transplant. Proc. |
pmid:12962832
|
Lama R et al. |
Lung transplants with tacrolimus and mycophenolate mofetil: a review. |
2003 |
Transplant. Proc. |
pmid:12962866
|
Crespo-Leiro MG |
Tacrolimus in heart transplantation. |
2003 |
Transplant. Proc. |
pmid:12962869
|
Aumente Rubio MD et al. |
Clinical pharmacokinetics of tacrolimus in heart transplantation: new strategies of monitoring. |
2003 |
Transplant. Proc. |
pmid:12962871
|
Domenech N et al. |
Neither acute rejection nor immunosuppressant drug therapy (cyclosporine or tacrolimus) correlates with expression of either CD40 or CD154 on peripheral blood cells among human cardiac transplant patients. |
2003 |
Transplant. Proc. |
pmid:12962873
|
Peraira JR et al. |
High incidence of severe infections in heart transplant recipients receiving tacrolimus. |
2003 |
Transplant. Proc. |
pmid:12962875
|
Amstey MS |
Erosive lichen planus of the vulva and vagina. |
2003 |
Obstet Gynecol |
pmid:12962964
|
Saripalli YV et al. |
Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis. |
2003 |
J. Am. Acad. Dermatol. |
pmid:12963912
|
Sun DS et al. |
Intraportal donor bone marrow transplantation improves intestinal allograft survival in rats under FK506-based immunosuppression. |
2003 Jul-Aug |
J. Int. Med. Res. |
pmid:12964503
|
Bradley KN et al. |
Cyclic ADP-ribose increases Ca2+ removal in smooth muscle. |
2003 |
J. Cell. Sci. |
pmid:12966165
|
Hesselink DA et al. |
Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus. |
2003 |
Clin. Pharmacol. Ther. |
pmid:12966368
|
Kameda G et al. |
Unexpected high serum levels of tacrolimus after a single topical application in an infant. |
2003 |
J. Pediatr. |
pmid:12970650
|
Chisholm MA et al. |
Coadministration of tacrolimus with anti-acid drugs. |
2003 |
Transplantation |
pmid:12973105
|
Koch R et al. |
Cyclosporine A-induced achalasia-like esophageal motility disorder in a liver transplant recipient: successful conversion to tacrolimus. |
2003 |
Transplantation |
pmid:12973123
|
Ramasubbu K et al. |
Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based review. |
2003 |
Transpl Infect Dis |
pmid:12974791
|
Patel RR et al. |
The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis. |
2003 |
Arch Dermatol |
pmid:12975161
|
Nagao K et al. |
A case of generalized pustular psoriasis treated with topical tacrolimus. |
2003 |
Arch Dermatol |
pmid:12975175
|
Seino Y et al. |
Multicenter prospective investigation on cardiovascular adverse effects of tacrolimus in kidney transplantations. |
2003 |
Cardiovasc Drugs Ther |
pmid:12975596
|
Gailliot FP et al. |
Fluidized bed adsorption for whole broth extraction. |
1990 Sep-Oct |
Biotechnol. Prog. |
pmid:1366874
|
Stoopler ET et al. |
Oral lichen planus. Update for the general practitioner. |
2003 Jun-Jul |
N Y State Dent J |
pmid:13677863
|
Levay-Young B et al. |
Intestinal graft versus native liver cytokine expression in a rat model of intestinal transplantation with and without donor-specific cell augmentation. |
2003 |
J. Surg. Res. |
pmid:13678702
|
Chiheb S et al. |
[Behçet's disease]. |
2003 Jun-Jul |
Ann Dermatol Venereol |
pmid:13679709
|
Thomson AW et al. |
FK 506, cardiac transplantation, and graft-vessel disease. |
1992 |
Lancet |
pmid:1370563
|
First MR |
Transplantation in the nineties. |
1992 |
Transplantation |
pmid:1370734
|
Naito M et al. |
Reversal of multidrug resistance by an immunosuppressive agent FK-506. |
1992 |
Cancer Chemother. Pharmacol. |
pmid:1370765
|
Yem AW et al. |
The Hsp56 component of steroid receptor complexes binds to immobilized FK506 and shows homology to FKBP-12 and FKBP-13. |
1992 |
J. Biol. Chem. |
pmid:1371107
|
Park ST et al. |
PPIase catalysis by human FK506-binding protein proceeds through a conformational twist mechanism. |
1992 |
J. Biol. Chem. |
pmid:1371117
|
Bishop DK and Li W |
Cyclosporin A and FK506 mediate differential effects on T cell activation in vivo. |
1992 |
J. Immunol. |
pmid:1371128
|
Hatfield SM and Roehm NW |
Cyclosporine and FK506 inhibition of murine mast cell cytokine production. |
1992 |
J. Pharmacol. Exp. Ther. |
pmid:1371158
|
Takaya S et al. |
The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. |
1992 |
Transplantation |
pmid:1371195
|
Francavilla A et al. |
Inhibition of liver, kidney, and intestine regeneration by rapamycin. |
1992 |
Transplantation |
pmid:1371198
|
First MR |
Renal transplantation for the nephrologist: new immunosuppressive drugs. |
1992 |
Am. J. Kidney Dis. |
pmid:1371201
|
Matsukawa W et al. |
Effects of a new immunosuppressive agent, FK506, in rats with active Heymann nephritis. |
1992 |
J. Lab. Clin. Med. |
pmid:1371298
|
Sampson BA and Gotschlich EC |
Neisseria meningitidis encodes an FK506-inhibitable rotamase. |
1992 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1371354
|
Andersson J et al. |
Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. |
1992 |
Immunology |
pmid:1371491
|
Strasser S et al. |
Effect of FK506 on insulin secretion in normal dogs. |
1992 |
Metab. Clin. Exp. |
pmid:1371575
|
Andersson J et al. |
FK 506 and cyclosporine inhibit antigen- or mitogen-induced monokine and lymphokine production in vitro. |
1992 |
Transplant. Proc. |
pmid:1371621
|
Matsuura T et al. |
Blockade of interleukin-2 production from cloned T cells by cyclosporine and FK 506 assessed by proliferation assays in vitro. |
1992 |
Transplant. Proc. |
pmid:1371623
|
Okamura N et al. |
Enhanced liver regeneration by FK 506 can be blocked by interleukin-1 alpha and interleukin-2. |
1992 |
Transplant. Proc. |
pmid:1371624
|
Sakr M et al. |
Effect of renal ischemia on plasma levels of FK 506 in rats. |
1992 |
Transplant. Proc. |
pmid:1371625
|
Kusne S et al. |
Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation. |
1992 |
Transplant. Proc. |
pmid:1371626
|
Lee C et al. |
FK-506 binding protein from Tolypocladium inflatum: resistance of FKBP/FK-506 complex against proteolysis. |
1992 |
Biochem. Biophys. Res. Commun. |
pmid:1371677
|
Edkins RD et al. |
Comparison of cyclosporine and FK506 effects on glutathione levels in rat cochlea, brain, liver and kidney. |
1992 |
Biochem. Pharmacol. |
pmid:1371687
|
Galat A et al. |
A rapamycin-selective 25-kDa immunophilin. |
1992 |
Biochemistry |
pmid:1371698
|
Hanawa H et al. |
An immunosuppressant compound, FK-506, prevents the progression of autoimmune myocarditis in rats. |
1992 |
Clin. Immunol. Immunopathol. |
pmid:1371730
|
Hiraoka Y et al. |
The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis. |
1992 |
J. Pharmacol. Exp. Ther. |
pmid:1372051
|
Chen TS et al. |
Microbial transformation of immunosuppressive compounds. I. Desmethylation of FK506 and immunomycin (FR 900520) by Actinoplanes sp. ATCC 53771. |
1992 |
J. Antibiot. |
pmid:1372307
|
Morisaki M and Arai T |
Identity of immunosuppressant FR-900520 with ascomycin. |
1992 |
J. Antibiot. |
pmid:1372308
|
Doi R et al. |
Effects of FK506 on exocrine pancreas in rats. |
1992 |
Pancreas |
pmid:1372739
|
Furukawa H et al. |
The effect of bile duct ligation and bile diversion on FK506 pharmacokinetics in dogs. |
1992 |
Transplantation |
pmid:1373531
|
Sakr M et al. |
Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients. |
1992 |
Transplantation |
pmid:1373535
|
Hirano Y et al. |
Morphological and functional changes of islets of Langerhans in FK506-treated rats. |
1992 |
Transplantation |
pmid:1373536
|
Takahara S et al. |
The in vitro immunosuppressive effect of deoxymethylspergualin in man as compared with FK506 and cyclosporine. |
1992 |
Transplantation |
pmid:1373537
|
Johnson MC et al. |
QT prolongation and Torsades de Pointes after administration of FK506. |
1992 |
Transplantation |
pmid:1373538
|
Kim YI et al. |
Stimulation of liver regeneration by pretreatment with azathioprine as well as cyclosporine and FK506. |
1992 |
Transplantation |
pmid:1373539
|
Carobbi A et al. |
Synergism of splenectomy and immunosuppressive drugs in prolongation of cardiac xenograft survival. |
1992 |
Transplant. Proc. |
pmid:1373543
|
Ueno M et al. |
Immunosuppressive effect in combination therapy of cyclosporine A, FK 506, and 15-deoxyspergualin on pancreatic islet xenotransplantation. |
1992 |
Transplant. Proc. |
pmid:1373546
|
Matsuzaki T et al. |
Liver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in rats. |
1992 |
Transplant. Proc. |
pmid:1373547
|
Mizuno K et al. |
Modulation of multidrug resistance by immunosuppressive agents: cyclosporin analogues, FK506 and mizoribine. |
1992 Jan-Feb |
Anticancer Res. |
pmid:1373592
|
Vincent SH et al. |
In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes: identification of a major metabolite and of cytochrome P450 3A as the major enzymes responsible for its metabolism. |
1992 |
Arch. Biochem. Biophys. |
pmid:1373595
|
Liu J et al. |
Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. |
1992 |
Biochemistry |
pmid:1373650
|
Adachi A et al. |
Immunosuppressive effect of FK506 on experimental allergic neuritis in Lewis rats: change of T cell subsets. |
1992 |
Intern. Med. |
pmid:1373661
|
Fruman DA et al. |
Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. |
1992 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1373887
|
Lake JR et al. |
Maintenance immunosuppression after liver transplantation. |
1992 |
Semin. Liver Dis. |
pmid:1373916
|
Taormina D et al. |
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers. |
1992 |
Am J Hosp Pharm |
pmid:1373936
|
Ochiai T |
[Advances in the fundamentals and therapeutic use of immunosuppressive agents]. |
1992 |
Arerugi |
pmid:1374229
|
Hung DT and Schreiber SL |
cDNA cloning of a human 25 kDa FK506 and rapamycin binding protein. |
1992 |
Biochem. Biophys. Res. Commun. |
pmid:1374240
|
Jayaraman T et al. |
FK506 binding protein associated with the calcium release channel (ryanodine receptor). |
1992 |
J. Biol. Chem. |
pmid:1374404
|
Höllsberg P et al. |
Characterization of HTLV-I in vivo infected T cell clones. IL-2-independent growth of nontransformed T cells. |
1992 |
J. Immunol. |
pmid:1374452
|
Schreiber SL and Crabtree GR |
The mechanism of action of cyclosporin A and FK506. |
1992 |
Immunol. Today |
pmid:1374612
|
Demetris AJ et al. |
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. |
1992 |
Transplantation |
pmid:1374944
|
Bundick RV et al. |
FK506 as an agonist to induce inhibition of interleukin 2 production. |
1992 |
Transplantation |
pmid:1374947
|
Sakr M et al. |
The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats. |
1992 |
Transplantation |
pmid:1374948
|
Lepre CA et al. |
Solution structure of FK506 bound to FKBP-12. |
1992 |
FEBS Lett. |
pmid:1375171
|
Ruff VA et al. |
FKBP-12 is not an inhibitor of protein kinase C. |
1992 |
Immunol. Invest. |
pmid:1375189
|
Kawaguchi S |
[Effects of FK506 on aminonucleoside-induced nephrotic rats]. |
1992 |
Nihon Jinzo Gakkai Shi |
pmid:1375300
|
Sigal NH and Dumont FJ |
Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. |
1992 |
Annu. Rev. Immunol. |
pmid:1375473
|
Chen TS et al. |
Microbial transformation of immunosuppressive compounds. II. Specific desmethylation of 13-methoxy group of FK 506 and FR 900520 by an unidentified Actinomycete ATCC 53828 [corrected]. |
1992 |
J. Antibiot. |
pmid:1375593
|
Meingassner JG and Stütz A |
Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases? |
1992 |
J. Invest. Dermatol. |
pmid:1375617
|
Schneck FX et al. |
Pediatric renal transplantation under FK-506 immunosuppression. |
1992 |
J. Urol. |
pmid:1375663
|
Connelly PR and Thomson JA |
Heat capacity changes and hydrophobic interactions in the binding of FK506 and rapamycin to the FK506 binding protein. |
1992 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1375751
|
Lancaster JR et al. |
EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. |
1992 |
J. Biol. Chem. |
pmid:1375934
|
Hirai T et al. |
The immunosuppressive effect of FK 506 on canine lung transplantation. |
1992 |
J. Thorac. Cardiovasc. Surg. |
pmid:1375967
|
Tai PK et al. |
Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex. |
1992 |
Science |
pmid:1376003
|
Jegasothy BV et al. |
Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. |
1992 |
Arch Dermatol |
pmid:1376102
|